Weak US data hampers FTSE recovery
Market heavyweights AstraZeneca and embattled BP made steady gains today, but weak US jobs data limited the recovery on the wider FTSE 100 Index.
The FTSE 100 made subdued progress as survey data showed far lower than expected jobs growth among US private employers in June.